CapsoVision (CV) finance chief awarded 92,212 stock options at $6.90 strike

Rhea-AI Filing Summary

CapsoVision, Inc reported that Sr. VP of Finance David Michael Garcia received a grant of stock options covering 92,212 shares of common stock. The options have an exercise price of $6.90 per share and expire on June 1, 2036.

The grant is compensation-related, with no cash changing hands at the time of grant. Following this award, Garcia holds options for a total of 257,212 underlying shares. According to the vesting terms, 25% of the options vest on June 1, 2027, and the remaining 75% vest in 36 equal monthly installments through June 1, 2030, subject to continued service.

Insights

Equity compensation analyst

Routine option grant increases executive equity incentives at CapsoVision.

Sr. VP of Finance David Michael Garcia received 92,212 stock options with a $6.90 exercise price, expiring on June 1, 2036. This is a non-cash, compensation-related award classified as a grant/award acquisition, not an open-market purchase.

The options vest 25% on June 1, 2027, with the remaining 75% in 36 monthly installments through June 1, 2030, contingent on continued service. After this grant, Garcia holds options over 257,212 shares, indicating a meaningful long-term equity stake tied to the company’s future performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Garcia David Michael

Role Sr. VP of Finance

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	92,212	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 257,212 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 92,212 options Exercise price: $6.90 per share Total options after grant: 257,212 options +3 more

6 metrics

Options granted 92,212 options Stock option grant on June 1, 2026

Exercise price $6.90 per share Stock option exercise price

Total options after grant 257,212 options Holdings following transaction

Expiration date June 1, 2036 Option term end

Initial vesting 25% on June 1, 2027 First vesting tranche

Remainder vesting period 75% over 36 months Monthly vesting through June 1, 2030

Key Terms

Stock Option (right to buy), exercise price, expiration date, vest, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 6.9000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-06-01T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest financial

"The options vest as to 25% of the shares subject to the option on June 1, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

installments financial

"and as to the remaining 75% of the shares in 36 equal monthly installments thereafter"

Installments are a series of scheduled partial payments that together cover a larger amount owed or due, like paying for a purchase or loan in weekly or monthly pieces rather than all at once. For investors, installments matter because they change when cash moves between parties, affect a company’s or counterparty’s short-term cash flow and risk of missed payments, and can influence valuation or perceived financial stability much like spreading the cost of a car over monthly payments.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garcia David Michael

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP of Finance

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$6.9	06/01/2026		A		92,212		(1)	06/01/2036	Common Stock	92,212	$0	257,212	D

Explanation of Responses:

1. The options vest as to 25% of the shares subject to the option on June 1, 2027 and as to the remaining 75% of the shares in 36 equal monthly installments thereafter through June 1, 2030, subject to continued service to the Issuer on each such date.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for David Garcia	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did CapsoVision (CV) executive David Michael Garcia receive in this Form 4?

David Michael Garcia received a grant of stock options for 92,212 shares of CapsoVision common stock. These options are part of his equity compensation and do not involve a cash purchase on the grant date.

What is the exercise price of the new CapsoVision (CV) stock options?

The newly granted stock options have an exercise price of $6.90 per share. This is the price Garcia must pay per share to convert options into common stock if he chooses to exercise in the future.

When do David Michael Garcia’s CapsoVision (CV) options vest?

Twenty-five percent of the options vest on June 1, 2027. The remaining 75% vest in 36 equal monthly installments through June 1, 2030, conditioned on Garcia’s continued service with CapsoVision on each vesting date.

How many CapsoVision (CV) option shares does Garcia hold after this grant?

After this grant, Garcia holds stock options over 257,212 underlying CapsoVision common shares. This total includes the newly granted 92,212 options and represents his reported direct derivative holdings following the transaction.

Is this CapsoVision (CV) Form 4 a stock purchase or a compensation grant?

This Form 4 reflects a compensation-related stock option grant, not an open-market stock purchase. The transaction code is “A” for grant or award, and the options were issued at an exercise price of $6.90 with no cash paid at grant.